BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 23947755)

  • 1. Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazole.
    Yang E; Yu KS; Lee S
    CPT Pharmacometrics Syst Pharmacol; 2023 Jun; 12(6):865-877. PubMed ID: 36967484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium citrate buffer improves pazopanib solubility and absorption in gastric acid-suppressed rat model.
    Muhammad HJ; Shimada T; Fujita A; Sai Y
    Drug Metab Pharmacokinet; 2024 Apr; 55():100995. PubMed ID: 38447327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Oral Care Foams and a Spray on Salivary pH Changes after Exposure to Acidic Beverages in Young Adults.
    Polyakova M; Egiazaryan A; Doroshina V; Zaytsev A; Malashin A; Babina K; Novozhilova N
    Dent J (Basel); 2024 Apr; 12(4):. PubMed ID: 38668005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coca-Cola consumption
    Liu FG; Meng DF; Shen X; Meng D; Liu Y; Zhang LY
    World J Gastrointest Endosc; 2024 Feb; 16(2):83-90. PubMed ID: 38464817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs.
    Matsumura N; Ono A; Akiyama Y; Fujita T; Sugano K
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Lipolysis Model to Predict Food Effect of Poorly Water-Soluble Drugs Itraconazole, Rivaroxaban, and Ritonavir.
    Patel RP; Cristofoletti R; Wu F; Shoyaib AA; Polli JE
    J Pharm Sci; 2024 Apr; ():. PubMed ID: 38614321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal products with pH-dependent solubility-A problem for BA/BE assessment?
    Blume H; Weitschies W
    Eur J Pharm Sci; 2024 May; 196():106756. PubMed ID: 38556065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers.
    Lange D; Pavao JH; Wu J; Klausner M
    J Clin Pharmacol; 1997 Jun; 37(6):535-40. PubMed ID: 9208361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole.
    Jaruratanasirikul S; Kleepkaew A
    Eur J Clin Pharmacol; 1997; 52(3):235-7. PubMed ID: 9218932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advancements in mechanical reduction methods: particulate systems.
    Leleux J; Williams RO
    Drug Dev Ind Pharm; 2014 Mar; 40(3):289-300. PubMed ID: 23988193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omeprazole on the pharmacokinetics of itraconazole.
    Jaruratanasirikul S; Sriwiriyajan S
    Eur J Clin Pharmacol; 1998 Apr; 54(2):159-61. PubMed ID: 9626921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity.
    Lim SG; Sawyerr AM; Hudson M; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1993 Jun; 7(3):317-21. PubMed ID: 8117350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporotrichosis in Children: Case series and Narrative Review.
    Queiroz-Telles F; Bonifaz A; Cognialli R; Lustosa BPR; Vicente VA; Ramírez-Marín HA
    Curr Fungal Infect Rep; 2022; 16(2):33-46. PubMed ID: 35284035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats.
    Almomen A; Maher HM; Alzoman NZ; Shehata SM; Alsubaie A
    PeerJ; 2020; 8():e9881. PubMed ID: 33024629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola
    Hens B; Bermejo M; Cristofoletti R; Amidon GE; Amidon GL
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32570975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole.
    Li Z; Zhang M; Liu C; Zhou S; Zhang W; Wang T; Zhou M; Liu X; Wang Y; Sun Y; Sun J
    Asian J Pharm Sci; 2017 Mar; 12(2):157-164. PubMed ID: 32104325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Cytochrome P450 3A4-Mediated Drug-Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation.
    Budha NR; Ji T; Musib L; Eppler S; Dresser M; Chen Y; Jin JY
    Clin Pharmacokinet; 2016 Nov; 55(11):1435-1445. PubMed ID: 27225997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.
    Abuhelwa AY; Foster DJ; Mudge S; Hayes D; Upton RN
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5681-96. PubMed ID: 26149987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic understanding of the effect of PPIs and acidic carbonated beverages on the oral absorption of itraconazole based on absorption modeling with appropriate in vitro data.
    Fotaki N; Klein S
    Mol Pharm; 2013 Nov; 10(11):4016-23. PubMed ID: 23947755
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.